TP53 and neoplasm: Genetic abrogation of tumor suppressors such as p53 or p16 revokes the tumor-suppressive barrier, thereby facilitating oncogene-induced tumorigenesis (Carragher et al., 2010; Bennecke et al., 2010; Dankort et al., 2007; Sarkisian et al., 2007).